2021
Getting personal about skin: Realizing precision medicine in dermatology
Brownstone N, Wu J, Strober B, Dickerson T. Getting personal about skin: Realizing precision medicine in dermatology. Dermatological Reviews 2021, 2: 289-295. DOI: 10.1002/der2.99.Peer-Reviewed Original ResearchDisease statesImproved clinical outcomesPersonalized medicinePrecision medicine toolsEfficient patient careAtopic dermatitisClinical outcomesTreatment paradigmIndividual patientsField of dermatologyPatient carePatientsMedicine toolsTreatment of diseasesMedicine testsHealthcare expendituresClinical dermatologyDermatologyHealthcare systemPrecision medicineTreatmentDiagnosisPersonalized medicine testsBiomarkersMedicine
2017
Clinical trials: Kids are not just little people
Naka F, Strober B, Shahriari M. Clinical trials: Kids are not just little people. Clinics In Dermatology 2017, 35: 583-593. PMID: 29191349, DOI: 10.1016/j.clindermatol.2017.08.008.Peer-Reviewed Original Research
2012
Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know
Strober B, Armour K, Romiti R, Smith C, Tebbey P, Menter A, Leonardi C. Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know. Journal Of The American Academy Of Dermatology 2012, 66: 317-322. PMID: 22243723, DOI: 10.1016/j.jaad.2011.08.034.Peer-Reviewed Original ResearchConceptsTreatment of psoriasisOptimal therapy managementImmune-mediated disordersBiosimilar formPsoriasis populationAppropriate therapyTopical agentsTherapy managementBiosimilar agentsClinical relevanceGeneric therapiesPatient careTherapyPsoriasisImportant interventionDevelopment of biosimilarsPatientsBiosimilarsDermatologistsTreatmentBiopharmaceutical therapiesAgentsImportant differencesPrescribersRegulatory guidelines